Selective Wealth Management, Inc. Gilead Sciences, Inc. Transaction History

Selective Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 21, 2022	BUY	$59.54 - $68.01 $1,071 - $1,224	18 New	18 $1,000
Q3 2020 Oct 21, 2020	SELL	$62.1 - $78.08 $5,278 - $6,636	-85 Reduced 45.95%	100 $6,000
Q4 2019 Jan 10, 2020	BUY	$61.62 - $67.78 $61 - $67	1 Added 0.54%	185 $12,000
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $11,501 - $12,696	184 New	184 $11,000
Q1 2019 Apr 04, 2019	SELL	$62.53 - $70.05 $12,506 - $14,010	-200 Closed	0 $0
Q3 2018 Oct 12, 2018	BUY	$71.28 - $78.92 $14,256 - $15,784	200 New	200 $15,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Selective Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Selective Wealth Management, Inc. with notifications on news.